Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 40.05
-0.95 (-2.32%)
At close: Jun 2, 2026
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 3.97 billion as of June 2, 2026. Its market cap has increased by 1.09% in one year.
Market Cap
3.97B
Enterprise Value
3.24B
Revenue
46.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.05
Market Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 3.97B, an increase of 33.06%. That is a compound annual growth rate of 7.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 3.97B | -18.55% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
| Apr 12, 2022 | 2.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Wecome Pharmaceutical Company | 4.38B |
| ChemPartner PharmaTech | 4.30B |
| Wuhan Hvsen Biotechnology | 4.29B |
| Beijing Scitop Bio-tech | 4.27B |
| Kexing Biopharm | 4.18B |
| Beijing Bohui Innovation Biotechnology Group | 4.16B |
| Hefei Lifeon Pharmaceutical | 3.86B |
| Shanghai Serum Bio-Technology | 3.84B |